Tenon Medical Announces Treatment of First Patient in Strategic Post Market Clinical Study with Company's Catamaran(TM) SI Joint Fusion System

Stock Information for Tenon Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Tenon Medical Inc.

Tenon(R) Medical Appoints Kristine Jacques to its Board of Directors
Tenon(R) Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran(R) SI Joint Fusion System
Tenon Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results
Tenon Medical, Inc. Raises Approximately $2.6 Million in Series A Preferred Stock
Tenon Medical, Inc. Announces Second Adjournment of Special Meeting of Stockholders
Tenon Medical, Inc. Announces Adjournment of Special Meeting of Stockholders
Tenon Medical Announces Participation in Two Key Immersive Webinar Physician Training Programs Featuring the Company's Catamaran(R) SI Joint Fusion System

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.